A Post-marketing Observational Database Study Monitoring the Safety of CecolinⓇ

Clinical trial NCT06824896 · COMPLETED

Trial details

NCT number: NCT06824896
Sponsor: Xiamen Innovax Biotech Co., Ltd
Status: COMPLETED
Study type: OBSERVATIONAL

Autoimmune Diseases Adverse Pregnancy Outcomes

Start date: 2023-06-06
Primary completion: 2024-06-30
Enrollment: 1322084

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.